Ozempic and other GLP-1RAs - impact on ME/CFS

Dr Ruhoy, from memory, is someone who jumps on ever bandwagon, and the article says she's about to have a book published. Cort's articles also tend to be overenthusiastic about every treatment anyone is hyping. Until there is research evidence, I reserve judgement.
 
Dr. Ruhoy is going to be part of a new film still untitled that focuses on the journey of patients with ME, MCAS, EDS, CCI, LC and POTS.

Includes patients stories about navigating their health and illness.
 
Been on Wegovy for 6 months and I do have 10% less weight to carry so obviously I’m using a bit less energy moving around. but it hasn’t had any noticeable impact on my pain, sleep, orthostatic, cognitive symptoms.

To give an example my rule is to not go back upstairs during the day as it uses a lot of energy. Since losing some weight i find it doable to get back upstairs if needed only when I’ve not done anything much during the day. But If I’ve been out or done some house chores I still find I’m semi crawling having to make a big effort to get upstairs at the end of my day.
 
Chestnut tree said:
It seems like these drugs are promoted for a lot of health complaints. But do we know enough about long term safety?

And even in the short term it seems these medications can cause harm.
Click to expand...

Given that a whopping one in eight American adults have now tried a GLP-1 agonist, we have a huge sample size for these type of drugs already, which means their side effects are already quite well understood.

https://edition.cnn.com/2024/05/10/health/ozempic-glp-1-survey-kff
 
Does anyone have any idea about which type (GLP-1 vs Dual GIP/GLP-1 receptor agonists) might be safer for keeping muscles intact and or which could possibly be more potent against neuroinflammation?
 
You must log in or register to reply here.
Back
Top Bottom